Table 2.
Demographics of PAD patients with or without mortality.
| Demographics | Total (n = 86) | Survival ( n = 76) | Mortality (n = 10) | p Value | |
|---|---|---|---|---|---|
| Age | 71.65 ± 10.90 | 71.89 ± 10.05 | 71.67 ± 16.00 | 0.951 | |
| Sex (male/female) | 50/36 | 44/32 | 6/4 | 1.000 | |
| Body mass index | 23.94 ± 3.82 | 24.11 ± 3.69 | 23.46 ± 4.50 | 0.321 | |
| Smoking | 33.3% | 33.8% | 30.0% | 1.000 | |
| Diabetes mellitus | 73.3% | 75.0% | 60.0% | 0.447 | |
| Dyslipidemia | 42.2% | 43.8% | 30.0% | 0.507 | |
| Hypertension | 84.9% | 86.8% | 70.0% | 0.172 | |
| Congestive heart failure | 17.4% | 17.1% | 20.0% | 1.000 | |
| Stroke | 15.1% | 14.5% | 20.0% | 0.644 | |
| End stage renal disease | 41.2% | 38.7% | 60.0% | 0.305 | |
| Coronary artery disease | 55.8% | 56.6% | 50.0% | 0.744 | |
| Rutheford grade | 3: severe claudication | 22.6% | 24.3% | 10% | 0.443 |
| ≥4: critical limb ischemia | 77.4% | 75.7% | 90% | ||
| YKL-40 (ng/mL) | 406.74 ± 286.66 | 405.19 ± 299.00 | 418.47 ± 175.90 | 0.408 | |
| rs4950928 G-allele carriers | 29.1% | 30.3% | 20% | 0.502 | |